Radiation therapy is the treatment of cancer and other diseases with radiation. Radiation in various forms is used to kill the cancer cells by preventing them from multiplying. Therapeutic radiology may be used to cure or control cancer, or to alleviate some of the symptoms associated with cancer. Gen Consulting Company が発表した市場調査によると, the global radiotherapy, nuclear medicine & radiopharmaceuticals market is expected to reach approximately USD 30,329 百万, representing a CAGR of 9.4% 予測期間中 2022-2028.

このレポートは、現在の世界市場シナリオに関する詳細な分析と洞察を提供します。, latest trends and drivers into global radiotherapy, nuclear medicine & radiopharmaceuticals market. 市場規模などのさまざまな詳細について独自の洞察を提供します, 主要なトレンド, 競争環境, 成長率と市場セグメント. This study also provides an analysis of the impact of the COVID-19 crisis on the radiotherapy, nuclear medicine & radiopharmaceuticals industry.

この業界レポートは、世界市場の市場推定と予測を提供します。, その後、製品の詳細な分析が行われます, 応用, と地域. The global market for radiotherapy, nuclear medicine & radiopharmaceuticals can be segmented by product: radiopharmaceuticals, radiotherapy. このうち, the radiopharmaceuticals segment was accounted for the highest revenue generator in 2021. Radiotherapy, nuclear medicine & radiopharmaceuticals market is further segmented by application: bone metastasis, endocrine tumor, hyperthyroidism, lymphoma, 腫瘍学, その他. 地域に基づく, the radiotherapy, nuclear medicine & radiopharmaceuticals market is segmented into: アジア太平洋地域, ヨーロッパ, 北米, 世界のその他の地域 (行).

製品別:
– radiopharmaceuticals
– radiotherapy

用途別:
– bone metastasis
– endocrine tumor
– hyperthyroidism
– lymphoma
– 腫瘍学
– その他

地域別:
– アジア太平洋地域
– ヨーロッパ
– 北米
– 世界のその他の地域 (行)

The radiopharmaceuticals market is further segmented into diagnostic radiopharmaceuticals, therapeutic radiopharmaceuticals. The diagnostic radiopharmaceuticals segment captured the largest share of the market in 2021 予測期間中もその優位性を維持すると予想されます. さらに, the radiopharmaceuticals by production method market has been categorized into cyclotron, generator, nuclear reactor. The radiotherapy market is further divided into external beam radiation therapy, internal radiation therapy or brachytherapy, systemic radiotherapy.

The market research report covers the analysis of key stake holders of the global radiotherapy, nuclear medicine & radiopharmaceuticals market. Some of the leading players profiled in the report include Accuray Inc., Advanced Accelerator Applications (Novartis International AG), Australian Nuclear Science and Technology Organisation (ANSTO), Bracco S.p.A., Cardinal Health, 株式会社, Curium SAS, Eckert & Ziegler Strahlen- und Medizintechnik AG, ECZACIBASI-MONROL Nuclear Products Co., Elekta AB, GEヘルスケア, IBA Molecular (IBAM), IRE – IRE ELiT, Jubilant Life Sciences Ltd., Lantheus Holdings, 株式会社, Nordion Inc, NTP Radioisotopes SOC Ltd., Varian Medical Systems Inc., とりわけ.
*無料サンプルをリクエストして企業の完全なリストを入手してください

歴史的 & 予測期間
この調査レポートは、以下の各セグメントの分析を提供します。 2018 に 2028 検討中 2021 基準年となる.

報告書の範囲
– To analyze and forecast the market size of the global radiotherapy, nuclear medicine & radiopharmaceuticals market.
– To classify and forecast the global radiotherapy, nuclear medicine & radiopharmaceuticals market based on product, 応用, 領域.
– To identify drivers and challenges for the global radiotherapy, nuclear medicine & radiopharmaceuticals market.
– 合併などの競争展開を検討するため & 買収, 協定, コラボレーションとパートナーシップ, 等, in the global radiotherapy, nuclear medicine & radiopharmaceuticals market.
– To identify and analyze the profile of leading players operating in the global radiotherapy, nuclear medicine & radiopharmaceuticals market.

このレポートを選択する理由
– Gain a reliable outlook of the global radiotherapy, nuclear medicine & radiopharmaceuticals market forecasts from 2022 に 2028 シナリオ全体にわたって.
– 投資対象となる成長セグメントを特定する.
– 会社概要と市場データを通じて競合他社に先んじる.
– Excel 形式でのシナリオ全体の分析を容易にするための市場予測.
– 3ヶ月間の戦略コンサルティングとリサーチサポート.
– シングルユーザーライセンスに提供される印刷認証.